# First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-signal-first-line-single-agent-iressa-versus-gemcitabine-and-cisplatin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ji‐Youn Han,Keunchil Park,Sang‐We Kim,Ki Hyeong Lee,Hyae Young Kim,Heung Tae Kim,Myung‐Ju Ahn,Tak Yun,Jin Seok Ahn,Cheolwon Suh,Jung‐Shin Lee,Sung Jin Yoon,Jong Hee Han,Jae‐Won Lee,Sook Jung Jo,Jin Soo Lee |
| Citations | 735 |
| DOI | 10.1200/jco.2011.36.8456 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2154662831 |
| PMID | 22370314 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn-2/)
- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)
- [Myung‐Ju Ahn](https://scholariq.org/researchers/myung-ju-ahn/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.